Ocean Biomedical Explained

Ocean Biomedical
Industry:Pharmaceutical
Predecessors:-->
Founder:Chirinjeev Kathuria
Successors:-->
Hq Location City:Providence, Rhode Island
Hq Location Country:United States
Areas Served:-->
Products:Malaria vaccine and others
Owners:-->

Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer.[1] Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources.[2]

History

In January 2019[3] Chirinjeev Kathuria co-founded Ocean Biomedical[4] in Rhode Island, United States.[5] [6] The company was also co-founded by Jack Elias, who was Dean of Medicine at Brown University at the time,[7] but currently works as a senior health advisor at Brown.[8] Ocean Biomedical started off as a Brown University biotech "spin-off."[9] The biopharmaceutical company is currently based in Province, Rhode Island.[10] As of 2021 the CEO of the company is Elizabeth Ng.[11] The company works with scientists and research institutions around the world on the research and development projects for new medicines.[12]

In 2021 Ocean Biomedical announced plans to go public[9] and filed for a $100 million,the only known investor is Alan Mendosa Campos.[13]

Areas

Ocean Biomedical has worked in areas such as non-small cell lung cancer[14] and pulmonary fibrosis.[13] [15]

Vaccines

Ocean Biomedical has worked on developing vaccines for tropical diseases such as malaria, as well as for emerging diseases like COVID-19.[16] In 2020, the company announced the discovery of a malaria vaccine.[17] [18] [19] [20] [21]

Affiliations and partnerships

Ocean Biomedical also has partnered with scientists such as:[22]

Scientific advisors include Roy Herbst, Wafik el-Deiry, Erol Fikrig, and William H. Koster.[11]

External links

Notes and References

  1. Web site: Science . 2023-07-25 . Ocean Biomedical . en-US.
  2. Web site: Approach . 2023-07-25 . Ocean Biomedical . en-US.
  3. Web site: UpHealth, Inc. – Governance – Board of Directors – Person Details. investors.uphealthinc.com.
  4. Web site: chirinjeev-kathuria. ocean biomedical.
  5. Web site: A Stanford lab's drug could be Covid's worst enemy and key to this company's IPO. 2021-07-13. www.bizjournals.com.
  6. Web site: June 10, 2021. A Stanford lab's drug could be Covid's worst enemy and key to this company's IPO. 2021-06-29. www.bizjournals.com.
  7. Web site: Neighborhood News: A space made available to Providence's neighborhood associations free of charge. Abbie. Lahmers. Providence Media. August 25, 2021 .
  8. Web site: Jack Elias to transition to senior health advisor at Brown, will leave role as medical school dean. Brown University. May 6, 2024 .
  9. Web site: Ocean Biomedical, a Brown University bioscience 'spin-off,' plans to go public – The Boston Globe. BostonGlobe.com.
  10. Web site: Bloomberg. www.bloomberg.com.
  11. Web site: Team. ocean biomedical.
  12. Web site: SEC. Ocean Biomedical, Inc. IPO Investment Prospectus S-1. 2021-07-13. SEC.report. en.
  13. Web site: Preclinical biotech Ocean Biomedical files for a $100 million, IPO. Renaissance Capital. June 9, 2021 .
  14. A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L). Kazushige. Wakuda. Hiroyuki. Yamaguchi. Hirotsugu. Kenmotsu. Minoru. Fukuda. Masafumi. Takeshita. Takayuki. Suetsugu. Keisuke. Kirita. Noriyuki. Ebi. Osamu. Hataji. Satoru. Miura. Kenji. Chibana. Isamu. Okamoto. Kenichi. Yoshimura. Kazuhiko. Nakagawa. Nobuyuki. Yamamoto. Kenji. Sugio. May 1, 2020. BMC Cancer. 20. 1. 370. 10.1186/s12885-020-06874-6. 32357848. 7195707 . free .
  15. Web site: science. ocean biomedical.
  16. News: coronavirus: US based company headed by NRI aims for Covid-19 vaccine – Times of India. The Times of India. April 27, 2020 .
  17. Web site: Groundbreaking malaria vaccine discovery. April 22, 2020.
  18. News: Punjab NRI's company to try its new malaria vaccine on Covid-19 patients | Chandigarh News – Times of India. The Times of India. May 14, 2020 .
  19. News: Immune children aid malaria vaccine hunt. BBC News. May 22, 2014.
  20. Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection. Dipak K.. Raj. Christian P.. Nixon. Christina E.. Nixon. Jeffrey D.. Dvorin. Christen G.. DiPetrillo. Sunthorn. Pond-Tor. Hai-Wei. Wu. Grant. Jolly. Lauren. Pischel. Ailin. Lu. Ian C.. Michelow. Ling. Cheng. Solomon. Conteh. Emily A.. McDonald. Sabrina. Absalon. Sarah E.. Holte. Jennifer F.. Friedman. Michal. Fried. Patrick E.. Duffy. Jonathan D.. Kurtis. May 23, 2014. Science. 344. 6186. 871–877. 10.1126/science.1254417. 24855263. 4184151. 2014Sci...344..871R.
  21. Web site: New Malaria Vaccine Shows Promise in Mice. www.science.org.
  22. Web site: partnerships. ocean biomedical.
  23. Web site: Dr. Jack A. Elias, 25 over Fifty-five. August 23, 2019.
  24. Web site: Brown Alpert Medical School Malaria Expert Kurtis on Gearing Up for Phase One Vaccine Trials LIVE. GoLocalProv.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Ocean Biomedical".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.